FindMyRecallSubscribe
Class I: serious health riskTerminated

Nova Products African Black Ant Recall

AFRICAN BLACK ANT, 2800 mg, 6 capsules per box, produced by: Qinghan Hongwei Bioengi…

Nova Products, Inc. · Aston, PA

Risk level
Class I
Reported by FDA
Sep 24, 2014
Recall ID
D-1596-2014
Check your lot numberHow we source this data

Summary

Nova Products recalled African Black Ant starting Mar 28, 2014. The FDA classified it as Class I (serious health risk) and published enforcement report D-1596-2014 on Sep 24, 2014. Reason: Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction. Status: Terminated.

Why it was recalled

Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction.

Product description

AFRICAN BLACK ANT, 2800 mg, 6 capsules per box, produced by: Qinghan Hongwei Bioengineering Company, No. 158, Renmin Road, Xining City.

Lot numbers, UPCs & expiration codes

2006-000926

Where it was sold

Nationwide to retailers and distributors

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1596-2014
Classification
Class I
Status
Terminated
Recall initiated
Mar 28, 2014
FDA report date
Sep 24, 2014
Quantity
Unknown
Recall type
Voluntary: Firm initiated
Recalling firm
Nova Products, Inc.

Original FDA data

Every field from FDA enforcement report D-1596-2014, exactly as published.

Show all FDA fields
City
Aston
State
PA
Status
Terminated
Country
United States
Event ID
67860
Address
5 Mount Pleasant Rd
Code information
2006-000926
Postal code
19014-1407
Report date
Sep 24, 2014
Product type
Drugs
Recall number
D-1596-2014
Classification
Class I
Recalling firm
Nova Products, Inc.
Product quantity
Unknown
Termination date
Aug 6, 2015
Reason for recall
Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction.
Voluntary / mandated
Voluntary: Firm initiated
Product description
AFRICAN BLACK ANT, 2800 mg, 6 capsules per box, produced by: Qinghan Hongwei Bioengineering Company, No. 158, Renmin Road, Xining City.
Distribution pattern
Nationwide to retailers and distributors
Recall initiation date
Mar 28, 2014
Initial firm notification
Press Release
Center classification date
Sep 18, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1596-2014, published Sep 24, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls